Livzon Pharmaceutical Group (1513.HK) Q2 2026 Earnings

23AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.57
0.65
0.73
0.82

Details

Expected EPS
0.81730780704
Actual EPS
0.7378473258
Surprise EPS
-0.08
Surprise Percent
+9.72%

Description

Livzon Pharmaceutical Group (1513.HK) has reported earnings of 0.7378473258 per share for Q2 2026.

0 Comments

Share your thoughts